15.01.2024 - Financial agenda for 2024 Villepinte, 15 January 2024: Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2024. Publications calendar 2023 ANNUAL REVENUE .
12.10.2023 - The CHMP issues an opinion in favour of granting an EU marketing authorisation for Elucirem (Gadopiclenol)with the indication of use for magnetic resonance imaging with contrast enhancement in adults and children aged 2 years and over If . Seite 1